BETA BLOCKERS AND CALCIUM-CHANNEL BLOCKERS - OTHER CALCIUM-CHANNEL BLOCKERS

The use of beta blockers with felodipine, isradipine, lacidipine, nicardipine, and nimodipine normally appears to be useful and safe. Changes in the pharmacokinetics of the beta blockers and calcium-channel blockers may also occur, but these changes do not appear to be clinically important. Note that additive hypotensive effects are likely, see antihypertensives.
Monitor the outcome of concurrent use for additive haemodynamic effects (e.g. hypotension or heart failure).